Precision Medicine: The pharma's new role in healthcare
6th International Conference on Pharmaceutical Science and Advanced Drug Delivery Systems
April 28, 2022 | Webinar
Ignacio Quiles Lara
WBY Ventures, USA
Keynote : J Pharmacol Ther Res
Abstract:
Launching new pharmaceutical products in today’s market can be challenging. In this demanding environment, yesterday’s product launch strategies can no longer be relied upon to yield the expected patient, digital, or business outcomes. To address this, the future generation of go-to-launch leaders will need to be business growth strategists, multi-channel experts, and not simply execution tacticians. We are on a journey of a thousand miles. Let’s start taking some steps towards this session. We will review, among other things, lead with evidence-based solutions, precision medicine, digital transformation, winning with data, unique pain-points, stand with multichannel, working to bridge gaps, empower patients, providers, and payers, harness the power of the agile way of working, and unlock new levels of value to get a winning launch-readiness strategy.
Biography:
Ignacio Quiles MSc, MBA, Ph.D., has 19+ years of managerial biopharmaceutical experience, including 6+ years at the biomedicine research level. My international experience covers the whole value chain from early discovery strategies through clinical development, go-to-market to commercialization, and reimbursement for cancer solutions. I have proudly led strategic businesses in Europe, North America, Canada, Japan, and Latin America. It seriously scaled my apprenticeship from talented and diverse people. These multicultural shocks and the executive trainings were capital in defining my learning agility and strategic thinking. Thanks to all of them, I can drive a better understanding of complex ecosystems, adequate outcome approaches and pursue innovative next-level collaborative solutions that aim to serve patients in urgent needs.
PDF HTML